Linked Life Data

17542899

Source:http://linkedlifedata.com/resource/pubmed/id/17542899

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-6-4
pubmed:abstractText
Nail psoriasis occurs in 7% to 40% of children, with a similar pattern of clinical presentation to that of adults. In 0.6% to 2.3% of the patients nail changes appear as the only sign of the disease, preceding other skin and articular involvement. No pediatric clinical trials are available yet, but considering the successful use of tazarotene for nail dystrophy therapy in adults, we chose this drug to treat a child.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0736-8046
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
332-3
pubmed:dateRevised
2009-3-3
pubmed:meshHeading
pubmed:articleTitle
Childhood nail psoriasis: a useful treatment with tazarotene 0.05%.
pubmed:affiliation
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy. lauradiluvio@yahoo.it
pubmed:publicationType
Journal Article, Case Reports